欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0515/003
药品名称
PREGABALIN PENSA
活性成分
pregabalin 150.0 mg
剂型
Capsule, hard
上市许可持有人
Towa Pharmaceutical S.p.A. via Enrico Tazzoli n. 6 20154 Milan Italy
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
许可日期
2015/03/10
最近更新日期
2023/02/07
药物ATC编码
N03AX16 pregabalin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
common_pil_Pregab_v014_cl
Date of last change:2022/06/02
Final Product Information
|
common_spc_Pregab_v014_cl
Date of last change:2022/06/02
Final Product Information
|
ACKNOWLEDGEMENT OF AN ACCEPTABLE NOTIFICATION
Date of last change:2022/06/02
Final SPC
|
SPC Pregabalin Pensa
Date of last change:2022/06/02
Final PL
|
PIL Pregabalin Pensa
Date of last change:2022/06/02
PAR
|
PAREN-DE 4221-4222_Pregabalin
Date of last change:2015/04/13
Final Labelling
|
1.3.1-labop-pregabalin-2014-11-05 4222
Date of last change:2015/04/13
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase